– USA, DE – Phreesia (NYSE: PHR) today announced the appointment of Dr. Lisa Egbuonu-Davis (M.D., MPH) to its Board of Directors, effective July 13, 2023.
“Throughout my career, I’ve seen the benefits of using patient-reported data to inform how to better care for patients first-hand,” said Dr. Egbuonu-Davis. “I pride myself on being an advocate for healthcare transformation, and I am truly excited by Phreesia’s vision to improve health outcomes by leveraging data. I look forward to bringing my unique perspective from years in both pharmaceuticals and diagnostics to support the company’s ongoing success.”
About Dr. Lisa Egbuonu-Davis
Dr. Egbuonu-Davis is the former VP of Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation, where she provided medical advice to influence research, partnership, and investment strategy across Danaher’s diagnostic platform businesses.
Dr. Egbuonu-Davis brings broad strategic and operational experience in pharmaceuticals, public health, and consulting, including expertise in developing and implementing research, commercialization, and investment strategies for various patient populations. Before her time at DH Diagnostics, she served as VP of Global Patient Centered Outcomes and Solutions at Sanofi, Inc., where she created patient programs, services, and tools to enhance adherence and health outcomes in patients with chronic conditions. In this role, she leveraged Phreesia’s Patient Activation Measure to strategically identify intervention needs for patient support services for optimal health outcomes. She also previously served as VP of U.S. Medical Operations at Pfizer, leading clinical and outcomes research.
About Phreesia
Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies, and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022—more than 1 in 10 trips across the U.S.—a scale that we believe allows us to make a meaningful impact. Offering patient-driven digital solutions for intake, outreach, education, and more, Phreesia enhances the patient experience, drives efficiency, and improves healthcare outcomes.
For more information: https://www.phreesia.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
